FDA DrugClass IINotable

FDA Recall: DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC 61919-482-60), 60 Caps; CYMBALTA

Date: 2026-07-01
Brand: Direct Rx
Category: Drug
FDA Class: Class II

Description

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Hazard

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Remedy

263 Bottles

Related Recalls